CGEOX
Price
$20.26
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Net Assets
153.96M
RNPCX
Price
$69.19
Change
+$0.04 (+0.06%)
Updated
Aug 15 closing price
Net Assets
158.96B
Interact to see
Advertisement

CGEOX vs RNPCX

Header iconCGEOX vs RNPCX Comparison
Open Charts CGEOX vs RNPCXBanner chart's image
Calamos Global Equity R6
Price$20.26
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets153.96M
American Funds New Perspective R3
Price$69.19
Change+$0.04 (+0.06%)
VolumeN/A
Net Assets158.96B
CGEOX vs RNPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 159B vs. CGEOX (154M). RNPCX pays higher dividends than CGEOX: RNPCX (0.22) vs CGEOX (0.00). CGEOX was incepted earlier than RNPCX: CGEOX (5 years) vs RNPCX (23 years). CGEOX (1.11) and RNPCX (1.06) have similar cost to investors . CGEOX is a more actively managed with annual turnover of: 78.00 vs. RNPCX (24.00). CGEOX has a lower initial minimum investment than RNPCX: CGEOX (0) vs RNPCX (250). RNPCX annual gain was more profitable for investors over the last year : 13.15 vs. CGEOX (8.63). CGEOX return over 5 years is better than : 39.72 vs. RNPCX (36.07).
CGEOXRNPCXCGEOX / RNPCX
Total Expense Ratio1.091.06103%
Annual Report Gross Expense Ratio1.111.06105%
Fund Existence5 years23 years-
Gain YTD15.44215.182102%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets154M159B0%
Annual Yield % from dividends0.000.22-
Returns for 1 year8.6313.1566%
Returns for 3 years51.4033.34154%
Returns for 5 years39.7236.07110%
Returns for 10 yearsN/A83.79-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBGSX16.76N/A
N/A
Bridge Builder Small/Mid Cap Growth
VGLSX10.97-0.02
-0.18%
VALIC Company I Global Strategy
GPTUX13.77-0.05
-0.38%
GuidePath® Tactical Allocation Svc
RYATX81.27-0.42
-0.51%
Rydex NASDAQ-100® A
ACWIX18.46-0.11
-0.59%
AMG GW&K Small/Mid Cap Growth I